CVs now established as exit route alongside M&A and IPO: Moelis’s Hammer
Secondaries buyers’ own specialisation is aiding in GPs’ interest to consider a CV in tandem with other exit options, Moelis & Co managing director Jeff Hammer said at NEXUS 2026.
3 March 2026•2 mins read
